These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 26959173)

  • 1. An in Vitro and in Vivo Investigation of Bivalent Ligands That Display Preferential Binding and Functional Activity for Different Melanocortin Receptor Homodimers.
    Lensing CJ; Freeman KT; Schnell SM; Adank DN; Speth RC; Haskell-Luevano C
    J Med Chem; 2016 Apr; 59(7):3112-28. PubMed ID: 26959173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Direct in Vivo Comparison of the Melanocortin Monovalent Agonist Ac-His-DPhe-Arg-Trp-NH
    Lensing CJ; Adank DN; Wilber SL; Freeman KT; Schnell SM; Speth RC; Zarth AT; Haskell-Luevano C
    ACS Chem Neurosci; 2017 Jun; 8(6):1262-1278. PubMed ID: 28128928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-activity relationships of the unique and potent agouti-related protein (AGRP)-melanocortin chimeric Tyr-c[beta-Asp-His-DPhe-Arg-Trp-Asn-Ala-Phe-Dpr]-Tyr-NH2 peptide template.
    Wilczynski A; Wilson KR; Scott JW; Edison AS; Haskell-Luevano C
    J Med Chem; 2005 Apr; 48(8):3060-75. PubMed ID: 15828845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Developing a Biased Unmatched Bivalent Ligand (BUmBL) Design Strategy to Target the GPCR Homodimer Allosteric Signaling (cAMP over β-Arrestin 2 Recruitment) Within the Melanocortin Receptors.
    Lensing CJ; Freeman KT; Schnell SM; Speth RC; Zarth AT; Haskell-Luevano C
    J Med Chem; 2019 Jan; 62(1):144-158. PubMed ID: 29669202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-operative regulation of ligand binding to melanocortin receptor subtypes: evidence for interacting binding sites.
    Kopanchuk S; Veiksina S; Petrovska R; Mutule I; Szardenings M; Rinken A; Wikberg JE
    Eur J Pharmacol; 2005 Apr; 512(2-3):85-95. PubMed ID: 15840392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of Novel Potent and Selective Agonists at the Melanocortin-3 Receptor.
    Carotenuto A; Merlino F; Cai M; Brancaccio D; Yousif AM; Novellino E; Hruby VJ; Grieco P
    J Med Chem; 2015 Dec; 58(24):9773-8. PubMed ID: 26599352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aza-scanning of the potent melanocortin receptor agonist Ac-His-D-Phe-Arg-Trp-NH.
    Boeglin D; Xiang Z; Sorenson NB; Wood MS; Haskell-Luevano C; Lubell WD
    Chem Biol Drug Des; 2006 Apr; 67(4):275-83. PubMed ID: 16629825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptoid-peptide hybrids as potent novel melanocortin receptor ligands.
    Kruijtzer JA; Nijenhuis WA; Wanders N; Gispen WH; Liskamp RM; Adan RA
    J Med Chem; 2005 Jun; 48(13):4224-30. PubMed ID: 15974575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Further evidence for ancient role of ACTH peptides at melanocortin (MC) receptors; pharmacology of dogfish and lamprey peptides at dogfish MC receptors.
    Haitina T; Takahashi A; Holmén L; Enberg J; Schiöth HB
    Peptides; 2007 Apr; 28(4):798-805. PubMed ID: 17306418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of potent selective competitive-antagonists of the melanocortin type 2 receptor.
    Bouw E; Huisman M; Neggers SJ; Themmen AP; van der Lely AJ; Delhanty PJ
    Mol Cell Endocrinol; 2014 Aug; 394(1-2):99-104. PubMed ID: 25017734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-terminal fatty acylated His-dPhe-Arg-Trp-NH(2) tetrapeptides: influence of fatty acid chain length on potency and selectivity at the mouse melanocortin receptors and human melanocytes.
    Todorovic A; Holder JR; Bauzo RM; Scott JW; Kavanagh R; Abdel-Malek Z; Haskell-Luevano C
    J Med Chem; 2005 May; 48(9):3328-36. PubMed ID: 15857138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A concise synthesis of 1,4-dihydro-[1,4]diazepine-5,7-dione, a novel 7-TM receptor ligand core structure with melanocortin receptor agonist activity.
    Szewczyk JR; Laudeman CP; Sammond DM; Villeneuve M; Minick DJ; Grizzle MK; Daniels AJ; Andrews JL; Ignar DM
    Bioorg Med Chem; 2010 Mar; 18(5):1822-33. PubMed ID: 20172734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Constitutive activity of neural melanocortin receptors.
    Tao YX; Huang H; Wang ZQ; Yang F; Williams JN; Nikiforovich GV
    Methods Enzymol; 2010; 484():267-79. PubMed ID: 21036237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and Structure-Activity Relationships of Substituted Urea Derivatives on Mouse Melanocortin Receptors.
    Singh A; Kast J; Dirain ML; Huang H; Haskell-Luevano C
    ACS Chem Neurosci; 2016 Feb; 7(2):196-205. PubMed ID: 26645732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of melanocortin receptors.
    Goetz AS; Ignar DM
    Curr Protoc Pharmacol; 2003 Nov; Chapter 1():Unit1.28. PubMed ID: 21956799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure and function of the potent cyclic and linear melanocortin analogues.
    Cho MK; Lee CJ; Lee CH; Li SZ; Lim SK; Baik JH; Lee W
    J Struct Biol; 2005 Jun; 150(3):300-8. PubMed ID: 15890278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteochemometric mapping of the interaction of organic compounds with melanocortin receptor subtypes.
    Lapinsh M; Veiksina S; Uhlén S; Petrovska R; Mutule I; Mutulis F; Yahorava S; Prusis P; Wikberg JE
    Mol Pharmacol; 2005 Jan; 67(1):50-9. PubMed ID: 15470082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feeding effects of melanocortin ligands--a historical perspective.
    Irani BG; Haskell-Luevano C
    Peptides; 2005 Oct; 26(10):1788-99. PubMed ID: 16046247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progress in the development of melanocortin receptor selective ligands.
    Irani BG; Holder JR; Todorovic A; Wilczynski AM; Joseph CG; Wilson KR; Haskell-Luevano C
    Curr Pharm Des; 2004; 10(28):3443-79. PubMed ID: 15579046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of putative agouti-related protein(87-132)-melanocortin-4 receptor interactions by homology molecular modeling and validation using chimeric peptide ligands.
    Wilczynski A; Wang XS; Joseph CG; Xiang Z; Bauzo RM; Scott JW; Sorensen NB; Shaw AM; Millard WJ; Richards NG; Haskell-Luevano C
    J Med Chem; 2004 Apr; 47(9):2194-207. PubMed ID: 15084118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.